Governance across business units
Map decision rights for technology deployment, data procurement, IP transactions and third-party assurance. Capture exceptions rather than relying on policy statements alone.
Public multinational enterprises face shareholder visibility, group-level controls and many local operating regimes. Innovation research should create a transparent evidence trail and clear decision ownership rather than a generic list of legal requirements.

Public multinational enterprises face shareholder visibility, group-level controls and many local operating regimes. Innovation research should create a transparent evidence trail and clear decision ownership rather than a generic list of legal requirements.
For public multinational business units, the relevant challenge is to coordinate innovation governance, risk evidence and multiple internal decision owners across jurisdictions. A useful assignment should separate the client’s preferred outcome from what the available evidence can genuinely demonstrate. That means fixing the scope before collecting documents, and identifying which comparisons would have practical consequences for investment, contracting, research or implementation.
The project should clarify who can authorize each action, how long an assumption remains valid and which external evidence or independent specialist is needed. Source-based research helps a decision maker compare credible options while leaving formal legal, technical certification, clinical or financial determinations to their proper authorities.
Map decision rights for technology deployment, data procurement, IP transactions and third-party assurance. Capture exceptions rather than relying on policy statements alone.
Review supplier provenance, AI testing summaries, contractual control ownership and business continuity records across the relevant delivery chain.
Prepare country-sensitive issue matrices, identify specialists and keep local opinions distinguishable from central business research.
A source register should record document ownership, date, geographic scope, available reproduction detail, conflicts and access limitations. This prevents a comparison of unlike documents from being presented as a verified conclusion.
This evidence stream should be supplied or independently located, dated and tagged to a responsible owner. For public multinational business units, the reviewer should record version differences, missing permissions, dependencies and material contrary evidence before relying on it for the proposed decision.
This evidence stream should be supplied or independently located, dated and tagged to a responsible owner. For public multinational business units, the reviewer should record version differences, missing permissions, dependencies and material contrary evidence before relying on it for the proposed decision.
This evidence stream should be supplied or independently located, dated and tagged to a responsible owner. For public multinational business units, the reviewer should record version differences, missing permissions, dependencies and material contrary evidence before relying on it for the proposed decision.
These are illustrative outputs for a possible engagement and are not assertions about previous client projects, regulated representation or guaranteed performance.
A structured global innovation governance matrix would identify source material, decision assumptions, options considered and unresolved questions. It should state what was actually examined, which conclusions depend on management inputs and what requires an external specialist. The format can be adapted to the decision, evidence maturity and geographic scope.
A structured supplier assurance register would identify source material, decision assumptions, options considered and unresolved questions. It should state what was actually examined, which conclusions depend on management inputs and what requires an external specialist. The format can be adapted to the decision, evidence maturity and geographic scope.
A structured multi-jurisdiction specialist referral list would identify source material, decision assumptions, options considered and unresolved questions. It should state what was actually examined, which conclusions depend on management inputs and what requires an external specialist. The format can be adapted to the decision, evidence maturity and geographic scope.
A listed group is standardizing AI procurement for its subsidiaries. The research designs comparable vendor diligence questions while marking where local data-law and financial disclosure specialists must decide.
The scenario illustrates how a research assignment might be scoped. It does not describe a named client, actual transaction, verified operating result or completed engagement. An initial assessment should include at least one adverse hypothesis and specify what evidence would lead the decision maker to postpone, narrow or abandon the proposed step.
The right measures are those that connect the proposed work to a decision. Each should identify an observation period, a method, an accountable owner and reasons why the indicator might be misleading:
Use a baseline comparison where possible. Preserve missing information as missing rather than converting it into a positive score. If different evidence sources cannot be normalized fairly, report them in parallel with an explicit explanation of the trade-off.
Agree the exact public multinational enterprise decision and its accountable owner; describe available resources, countries, time horizon and which outcomes would justify changing course.
Record sources, dates, ownership, permissions, uncertainty and negative evidence. A slide, product claim or patent family alone is not sufficient to establish operational or commercial suitability.
Compare a conservative baseline, an achievable pilot and a more ambitious alternative for public multinational business units. Write down assumptions, costs, failure conditions and the evidence needed to discriminate between them.
Provide a concise source-linked research note with confidence grades, identified handoffs, action owners and next tests. Update the register as material facts change.
Group-level research is not an audit of securities disclosures or legal compliance. Issuer filings and regulatory representations require appropriately appointed experts.
Scope, staffing and use of third-party materials must be agreed for the actual engagement. Advice that involves a regulated activity, professional opinion or independently certified outcome requires separate assessment by appropriately qualified professionals. Nothing on this page asserts that a particular credential, authorization or prior client result has been established.
Primary institutional reference: https://mneguidelines.oecd.org/
The institutional reference provides background context, not a certification of this consulting practice. Its applicability to a particular project must be checked against the source date, context and jurisdiction.
Begin with the decision owner, a one-page statement of the decision, its deadline, a description of the available records and an explicit list of questions that would change the result. This avoids commissioning research that cannot affect an actual investment or operating choice.
No. The work products described here are research and commercial decision-support formats. Patent filing, regulatory approval, securities advice, audit certification, jurisdiction-specific legal opinions and other reserved activities require qualified professionals and separate authorization.
Share a short, non-confidential summary of the technical or commercial problem, the countries involved, the decision date and the form of output needed. Sensitive source material should be exchanged only after an appropriate confidential intake process is agreed.
Send a non-confidential outline of the problem, decision owner, intended deliverable and timing. We can clarify a research-first scope and identify where specialist professional involvement is necessary.